From Ebola News Today : Breaking News, Live Updates & Top Stories | Vimarsana

News highlights on health security threats and countermeasures curated by Global Biodefense This week's selections include the surge in monkeypox cases

As the first monkeypox case in Scotland is reported, it's vital we work together to tackle the spread of misinformation, says Dr Derek Sloan.

From Ebola to COVID-19, epidemics are fueled by fear and misinformation. Vaccines are refused; people protest unwanted public health measures; and in the

The COVID-19 pandemic has raised plenty of questions about whether the planet’s declining health is what ails humans. The answer is yes, and it’s not a metaphorical response. Distorting the blue planet’s green cover, hollowing out dense forests and tacking tree plantations at will fuels the rise of diseases, a growing body of research shows. […]

Synopsis Last month, Merck exited the vaccine race, abandoning its two candidates after early clinical trials flopped. Now, in addition to testing two experimental COVID-19 drugs, the company says that it’s looking for ways to help competitors supply the world with vaccines. Reuters Merck, which was founded in 1891, has been in the vaccine business for more than 100 years, having developed some of the world’s most well-known vaccines, including those for mumps, hepatitis A and chickenpox. From Ebola to HIV to river blindness, American pharmaceutical giant Merck has been on the front line...